Movva N , Reichert H , Hooda N , Bylsma LC , Mitchell M , Cohen SS. 2023. Dietary eating patterns, dairy consumption, and anxiety: A systematic literature review. PLoS One 18(12):e0295975. doi: 10.1371/journal.pone.0295975 . PMID: 38153944.
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology , Systematic Review
Garrison K, Zhang W, Jensen I , Shah A, Brown S, Stephenson B, Yim C. Cost-utility analysis of roflumilast cream for plaque psoriasis, including intertriginous, from the Canadian societal perspective. Abstract EE303 . ISPOR EU 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: cost-utility analysis , Health Economics and Outcomes Research (HEOR)
Gutierrez M, Wild S, Compton A, Paine E, Jensen I , Shah A. Cost consequences of using clevidipine in neurological emergencies from the perspective of a US hospital. Abstract EE579 . ISPOR EU 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: cost-consequence , Health Economics and Outcomes Research (HEOR)
Gutierrez M, Wild S, Compton A, Paine E, Jensen I , Shah A. Cost consequences of using clevidipine in cardiac surgery from the perspective of a US hospital. Abstract EE734 . ISPOR EU 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: cost-consequence , Health Economics and Outcomes Research (HEOR)
Gutierrez M, Wild S, Compton A, Paine E, Jensen I , Shah A. Cost consequences of using clevidipine in acute hypertension from the perspective of a US hospital. Abstract EE125 . ISPOR EU 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: cost-consequence , Health Economics and Outcomes Research (HEOR)
Bean K, Miller B, Jensen I , Howle K, Wilds A, Walz M, et al. The societal costs of metachromatic leukodystrophy (MLD) in the United States. Abstract EE547 . ISPOR EU 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: cost-consequence , Health Economics and Outcomes Research (HEOR) , Metachromatic leukodystrophy (MLD)
Miller B, Russel-Szymczyk M, Jensen I , Shah A, Alexopoulos T, Herbert A, et al. Cost-consequence of cladribine tablets for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in the UK. Abstract EE658 . ISPOR EU 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: cost-consequence , Health Economics and Outcomes Research (HEOR)
Davies S, Boller E, Beaubrun A, Miller C, Jensen I . A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV Plus for the diagnosis of viral respiratory infections from a US health plan perspective. Abstract ID309 . AMP 2023 Annual Meeting & Expo.
View Abstract
Publication: Abstracts and Presentations
/ Topics: cost-consequence , Health Economics and Outcomes Research (HEOR) , respiratory distress syndrome
Bylsma LC , Pundole X, Ju C-H, Hooda N , Movva N , Elkhouly E, et al. 2023. Systematic literature review of the prevalence and prognostic value of delta-like ligand 3 protein expression in small cell lung cancer. Target Oncol 18(6):821-835; doi: 10.1007/s11523-023-01008-x . PMID: 37930513.
View Abstract
Publication: Manuscripts
/ Topics: Cancer , Epidemiology , Systematic Review
Franklin M, Emden MR, Bauer E, Nguyen AT, Sacks N , Kawamatsu S, Kawano Y, Mitrani-Gold FS, Joshi AV, Ju S, Preib MT. Prevalence of acute uncomplicated cystitis in Japan. Poster presentation, IDWeek, October 2023.
A Division of